Search Ontology:
ChEBI
oritavancin
- Term ID
- CHEBI:82699
- Synonyms
-
- (4''R)-22-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-arabino-hexopyranosyl)-N(3'')-((4'-chloro(1,1'-biphenyl)-4-yl)methyl)vancomycin
- (4''R)-22-O-(3-Amino-2,3,6-trideoxy-3-C-methyl-alpha-L-arabinohexopyranosyl)-N3''-(p-(p-chlorophenyl)benzyl)vancomycin
- Chlorobiphenyl-chloroeremomycin
- LY333328
- Definition
- A semisynthetic glycopeptide used (as its bisphosphate salt) for the treatment of acute bacterial skin and skin structure infections caused or suspected to be caused by susceptible isolates of designated Gram-positive microorganisms including MRSA.
- References
-
- CAS:171099-57-3
- Drug_Central:4678
- KEGG:C12034
- PMID:22941898
- PMID:23089749
- PMID:23261897
- PMID:23759507
- PMID:24035967
- PMID:24449768
- PMID:24505091
- PMID:24550323
- PMID:24897083
- PMID:24906505
- PMID:25022588
- PMID:25058176
- PMID:25118105
- PMID:25239268
- PMID:25294250
- PMID:25294303
- Reaxys:7608605
- Wikipedia:Oritavancin
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_functional_parent
-
- has_role
-
- inverse has_part
-
Phenotype
Phenotype resulting from oritavancin
Phenotype where environments contain oritavancin
Phenotype modified by environments containing oritavancin
Human Disease Model